Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACONW NASDAQ:BTTX NASDAQ:DHACW NYSE:UPHL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONWAclarion$0.03-8.9%$0.03$0.02▼$0.23N/AN/A13,014 shs160 shsBTTXBetter Therapeutics$0.00$0.00▼$0.00$4K0.888,242 shsN/ADHACWDigital Health Acquisition$0.03-0.3%$0.04$0.01▼$0.40N/AN/A71,147 shs2,220 shsUPHLUpHealth$0.00$0.00$0.00▼$0.05$6K0.52,133 shs220 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONWAclarion+0.38%-9.80%-22.61%-15.77%-25.21%BTTXBetter Therapeutics0.00%0.00%0.00%0.00%0.00%DHACWDigital Health Acquisition-0.30%+4.36%-31.63%-42.64%-11.84%UPHLUpHealth0.00%+200.00%+200.00%+200.00%+50.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONWAclarion$0.03-8.9%$0.03$0.02▼$0.23N/AN/A13,014 shs160 shsBTTXBetter Therapeutics$0.00$0.00▼$0.00$4K0.888,242 shsN/ADHACWDigital Health Acquisition$0.03-0.3%$0.04$0.01▼$0.40N/AN/A71,147 shs2,220 shsUPHLUpHealth$0.00$0.00$0.00▼$0.05$6K0.52,133 shs220 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONWAclarion+0.38%-9.80%-22.61%-15.77%-25.21%BTTXBetter Therapeutics0.00%0.00%0.00%0.00%0.00%DHACWDigital Health Acquisition-0.30%+4.36%-31.63%-42.64%-11.84%UPHLUpHealth0.00%+200.00%+200.00%+200.00%+50.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONWAclarion 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/ADHACWDigital Health Acquisition 0.00N/AN/AN/AUPHLUpHealth 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONWAclarion$77.88KN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/AN/AUPHLUpHealth$130M0.00N/AN/A$3.10 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONWAclarionN/AN/AN/AN/AN/AN/AN/AN/A8/28/2026 (Estimated)BTTXBetter Therapeutics-$39.76M-$0.78N/AN/AN/AN/AN/AN/A8/13/2026 (Estimated)DHACWDigital Health AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AN/AUPHLUpHealth-$56.42M$1.47N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthACONWAclarionN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/AUPHLUpHealthN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONWAclarionN/ABTTXBetter Therapeutics34.00%DHACWDigital Health AcquisitionN/AUPHLUpHealth56.10%Insider OwnershipCompanyInsider OwnershipACONWAclarionN/ABTTXBetter Therapeutics51.40%DHACWDigital Health AcquisitionN/AUPHLUpHealth34.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONWAclarion7N/AN/ANot OptionableBTTXBetter Therapeutics4040.58 million24.23 millionNo DataDHACWDigital Health AcquisitionN/AN/AN/ANot OptionableUPHLUpHealth1,75018.93 million12.45 millionNo DataBTTX, UPHL, ACONW, and DHACW HeadlinesRecent News About These CompaniesUpHealth Delays Latest Quarterly SEC FilingMay 15, 2026 | tipranks.comUpHealth Inc.May 14, 2026 | marketwatch.comUpHealth Delays Q2 2025 10-Q FilingAugust 14, 2025 | msn.comUpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo FinanceApril 23, 2025 | finance.yahoo.comLemon Dump Cake RecipeSeptember 9, 2024 | msn.comDJUSIV Dow Jones US Business Support Services IndexJuly 27, 2024 | seekingalpha.comUpHealth Inc Ordinary Shares UPHLJuly 19, 2024 | morningstar.comMUpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of AssetsMay 24, 2024 | prnewswire.comUpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for InvestorsApril 30, 2024 | zacks.comUpHealth, Inc. (UPHL)April 17, 2024 | finance.yahoo.comCalcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”April 16, 2024 | finance.yahoo.comUpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare SystemsApril 1, 2024 | finance.yahoo.comUpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 22, 2024 | finanznachrichten.deUpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 21, 2024 | finance.yahoo.comHealthcare Triangle GAAP EPS of -$1.26, revenue of $7.1MMarch 18, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBTTX, UPHL, ACONW, and DHACW Company DescriptionsAclarion NASDAQ:ACONW$0.03 0.00 (-8.87%) As of 06/16/2026 03:37 PM Eastern This is a fair market value price provided by Massive. Learn more.Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.Better Therapeutics NASDAQ:BTTXBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.Digital Health Acquisition NASDAQ:DHACW$0.03 0.00 (-0.30%) As of 06/15/2026Digital Health Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.UpHealth NYSE:UPHL$0.0003 0.00 (0.00%) As of 06/16/2026 11:42 AM EasternUpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Gravity Check: Houston, SpaceX Has a Valuation Problem Okta’s AI Moment May Be Bigger Than Investors Realize Could a Tesla-SpaceX Merger Be Closer Than Investors Think? Strategy’s Bitcoin Rally Has a Hidden Engine Is Lennar Finally Turning the Corner After Its Housing Slump? Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
